Gastric Cancer

Latest Advances in Immunotherapy for Gastric Cancer

by
Latest Advances in Immunotherapy for Gastric Cancer

Based on clinical research progress Keeping up with academic literature reports Inviting authoritative experts for interpretation “China Medical Forum” collaborates with “Baiyi Medical Department“ Monthly selection, classic every issue Sincerely invite attention to “Frontline of Immunotherapy for Gastrointestinal Cancer!“ Reviewing Experts Professor Xu Tongpeng MD, Associate Chief Physician of Oncology at Jiangsu Provincial People’s Hospital, … Read more

Serum FABP4, AFP, and MCP-1 Levels in Gastric Adenocarcinoma Patients

by
Serum FABP4, AFP, and MCP-1 Levels in Gastric Adenocarcinoma Patients

Gastric adenocarcinoma accounts for approximately 95% of gastric malignancies, predominantly occurring in individuals over 50 years of age. It exhibits low sensitivity to chemotherapy and radiotherapy, resulting in high incidence and mortality rates, with overall poor prognosis [1]. The disease typically presents no symptoms in its early stages; as it progresses, patients may experience gastric … Read more

Multi-Modal AI Analysis Technology Aids Precision Prediction of Treatment Response in HER2-Positive Gastric Cancer Patients

by
Multi-Modal AI Analysis Technology Aids Precision Prediction of Treatment Response in HER2-Positive Gastric Cancer Patients

On August 26, 2024, Professor Shen Lin’s team from Peking University Cancer Hospital and Professor Dong Bin’s team from Peking University published a groundbreaking research article titled “Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data” in Signal Transduction and Targeted Therapy (Impact Factor: 40.8). This study developed a … Read more